Capricor Therapeutics Inc
NASDAQ:CAPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
F
|
Ford Motor Co
LSE:0P4F
|
US |
|
E
|
Eastman Chemical Co
XMUN:EAC
|
US |
|
B
|
Banco Santander SA
SWB:BSD2
|
ES |
|
E
|
East Japan Railway Co
F:EJR
|
JP |
|
G
|
Getlink SE
DUS:TNU3
|
FR |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
OTC:MDIBF
|
IT |
|
E
|
Equity Residential
F:EQR
|
US |
|
Biodesix Inc
NASDAQ:BDSX
|
US |
|
Walmart Inc
NASDAQ:WMT
|
US |
Wall St Price Targets
CAPR Price Targets Summary
Capricor Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CAPR is 17.51 USD with a low forecast of 2.02 USD and a high forecast of 56.7 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CAPR's stock price target?
Price Target
17.51
USD
According to Wall Street analysts, the average 1-year price target for
CAPR is 17.51 USD with a low forecast of 2.02 USD and a high forecast of 56.7 USD.